NM_001200049.3:c.6922G>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001200049.3(CFAP46):c.6922G>A(p.Glu2308Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,613,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001200049.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP46 | ENST00000368586.10 | c.6922G>A | p.Glu2308Lys | missense_variant | Exon 49 of 58 | 5 | NM_001200049.3 | ENSP00000357575.4 | ||
CFAP46 | ENST00000639072.2 | c.6922G>A | p.Glu2308Lys | missense_variant | Exon 49 of 59 | 5 | ENSP00000491877.2 | |||
CFAP46 | ENST00000448925.1 | c.226G>A | p.Glu76Lys | missense_variant | Exon 3 of 5 | 3 | ENSP00000417039.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000442 AC: 11AN: 249030 AF XY: 0.0000371 show subpopulations
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461762Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727176 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74378 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1858G>A (p.E620K) alteration is located in exon 14 (coding exon 14) of the CFAP46 gene. This alteration results from a G to A substitution at nucleotide position 1858, causing the glutamic acid (E) at amino acid position 620 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at